Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.6 EUR
8.81 M EUR
47.18 M EUR
13.37 M
About Medistim ASA
Sector
Industry
CEO
Kari Eian Krogstad
Website
Headquarters
Oslo
Founded
1984
ISIN
NO0010159684
FIGI
BBG00N8TXLL1
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. It operates through the Own Products and Third Party Products segments. The Own Products segment leases and sells equipment. The Third Party Products segment markets medical devices purchased from third party manufacturers located in Denmark and Norway. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Medistim ASA stocks are traded under the ticker MD1.
We've gathered analysts' opinions on Medistim ASA future price: according to them, MD1 price has a max estimate of 26.34 EUR and a min estimate of 17.84 EUR. Watch MD1 chart and read a more detailed Medistim ASA stock forecast: see what analysts think of Medistim ASA and suggest that you do with its stocks.
Yes, you can track Medistim ASA financials in yearly and quarterly reports right on TradingView.
Medistim ASA is going to release the next earnings report on Oct 24, 2025. Keep track of upcoming events with our Earnings Calendar.
MD1 earnings for the last quarter are 0.20 EUR per share, whereas the estimation was 0.17 EUR resulting in a 17.65% surprise. The estimated earnings for the next quarter are 0.14 EUR per share. See more details about Medistim ASA earnings.
Medistim ASA revenue for the last quarter amounts to 14.75 M EUR, despite the estimated figure of 14.16 M EUR. In the next quarter, revenue is expected to reach 14.50 M EUR.
MD1 net income for the last quarter is 3.61 M EUR, while the quarter before that showed 3.81 M EUR of net income which accounts for −5.27% change. Track more Medistim ASA financial stats to get the full picture.
Yes, MD1 dividends are paid annually. The last dividend per share was 0.51 EUR. As of today, Dividend Yield (TTM)% is 2.40%. Tracking Medistim ASA dividends might help you take more informed decisions.
Medistim ASA dividend yield was 4.01% in 2024, and payout ratio reached 105.83%. The year before the numbers were 2.10% and 79.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 22, 2025, the company has 154 employees. See our rating of the largest employees — is Medistim ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medistim ASA EBITDA is 16.36 M EUR, and current EBITDA margin is 26.82%. See more stats in Medistim ASA financial statements.
Like other stocks, MD1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medistim ASA stock right from TradingView charts — choose your broker and connect to your account.